MicroRNA-451a downregulation in liraglutide-treated individuals with diabetes: A potential cardiovascular protective mechanism

Diabetes & Vascular Disease Research · Published 2024-09-01 · DOI 10.1177/14791641241278527

Authors being retrieved — see the publisher record. https://doi.org/10.1177/14791641241278527

Abstract

DOAJ holds no abstract for this record.

Read the article at the publisher →

Publication details

Year

2024

Related articles

• Type 1 diabetes mellitus disease burden in high health expenditure countries between 1990 and 2019 · Diabetes & Vascular Disease Research · 2023 · Same journal
• The triglyceride-glucose index and mortality in chronic kidney and cardiovascular disease patients: A cohort study · Diabetes & Vascular Disease Research · 2025 · Same journal
• Serum albumin-enhanced screening: A triage strategy and predictive model for OGTT in community-managed patients with coronary heart disease · Diabetes & Vascular Disease Research · 2026 · Same journal
• Relationship between non-O blood groups and microvascular risk in type 2 diabetes · Diabetes & Vascular Disease Research · 2026 · Same journal
• Analysis of the diabetic arterial transcriptome to define novel biomarkers of macrovascular disease · Diabetes & Vascular Disease Research · 2026 · Same journal
• A novel approach to diabetes-related foot ulcers/disease: First report of bipolar conventional RF lumbar sympathetic block · Diabetes & Vascular Disease Research · 2025 · Same journal
• Visceral adipose tissue accumulation and risk of organ complications among individuals with type 2 diabetes mellitus: A two-sample Mendelian randomization study · Diabetes & Vascular Disease Research · 2025 · Same journal
• Bioinformatics analyses of potential microRNAs and their target genes in myocardial infarction patients with diabetes · Diabetes & Vascular Disease Research · 2025 · Same journal
• Utility of bioelectrical phase angle for cardiovascular risk assessment among individuals with and without diabetes mellitus · Diabetes & Vascular Disease Research · 2024 · Same journal
• A pharmacoepidemiological nested case-control study of risk factors for venous thromboembolism with the focus on diabetes, cancer, socioeconomic group, medications, and comorbidities · Diabetes & Vascular Disease Research · 2024 · Same journal